Globeflex Capital L P Innoviva, Inc. Transaction History

Globeflex Capital L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$9.33 - $12.48 $257,993 - $345,096	-27,652 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$11.49 - $15.26 $317,721 - $421,969	27,652 New	27,652 $387,000
Q2 2019 Aug 12, 2019	SELL	$13.1 - $14.95 $91,700 - $104,650	-7,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$13.69 - $20.06 $797,374 - $1.17 Million	-58,245 Reduced 89.27%	7,000 $98,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $2,163 - $2,830	-155 Reduced 0.24%	65,245 $1.14 Million
Q3 2018 Nov 09, 2018	SELL	$13.63 - $15.7 $8,178 - $9,420	-600 Reduced 0.91%	65,400 $997,000
Q2 2018 Aug 10, 2018	SELL	$13.44 - $17.59 $13,440 - $17,590	-1,000 Reduced 1.49%	66,000 $911,000
Q4 2017 Feb 13, 2018	BUY	$11.73 - $14.75 $69,207 - $87,025	5,900 Added 9.66%	67,000 $951,000
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $736,866 - $862,732	61,100	61,100 $863,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.